bismuth has been researched along with gemcitabine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruchertseifer, F; Bryan, RA; Dadachova, E; Epstein, AL; Jandl, T; Jiang, Z; Koba, W; Morgenstern, A; Onyedika, C; Strauss, J | 1 |
1 other study(ies) available for bismuth and gemcitabine
Article | Year |
---|---|
Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Bismuth; Cell Line, Tumor; Cisplatin; Deoxycytidine; DNA; Female; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Radioimmunotherapy; Radioisotopes; Xenograft Model Antitumor Assays | 2014 |